MACK - Merrimack Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $127.73. This is a potential upside of $112.6 (744.22%) from yesterday's end of day stock price of $15.13.

Merrimack Pharmaceuticals's activity chart (see below) currently has 4 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 498 days.

Most recent stock forecast was given by LING WANG from on 10-Nov-2016. First documented stock forecast 12-Aug-2015.

Best performing analysts who are covering MACK - Merrimack Pharmaceuticals:

Ling Wang

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

8 years 11 months 23 days ago
(10-Nov-2016)

2/3 (66.67%)

$112.6 (301.07%)

498

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MACK (Merrimack Pharmaceuticals) average time for price targets to be met?

On average it took 498 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on MACK (Merrimack Pharmaceuticals) with a proven track record?

LING WANG

Which analyst has the most public recommendations on MACK (Merrimack Pharmaceuticals)?

Ling Wang has 9 price targets and 12 ratings on MACK

Which analyst is the currently most bullish on MACK (Merrimack Pharmaceuticals)?

Ling Wang with highest potential upside - $0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?